Log Out

US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist

3.730
+0.060+1.63%

Close Apr 23 16:00 ET

3.650
-0.080-2.14%

Post 16:06 ET

313.93MMarket Cap-2288P/E (TTM)

Atea Pharmaceuticals News

News

Announcement

Ratings

All

Earnings

Transactions

Shareholding

Events

Other

Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Feb 28 16:29 ET
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 8, 2023 16:15 ET
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
Aug 8, 2023 16:21 ET
Atea Pharmaceuticals | 8-K: Current report
Jun 21, 2023 17:02 ET
Atea Pharmaceuticals | DEFA14A: Others
Jun 12, 2023 08:19 ET
Atea Pharmaceuticals | DEFA14A: Others
May 25, 2023 17:22 ET
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
May 8, 2023 16:15 ET
Atea Pharmaceuticals | DEFA14A: Others
Apr 28, 2023 16:13 ET
Atea Pharmaceuticals | DEF 14A: Definitive proxy statements
Apr 28, 2023 16:07 ET
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Feb 28, 2023 16:12 ET
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Nov 7, 2022 16:16 ET
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Aug 8, 2022 16:11 ET
Atea Pharmaceuticals | 8-K: Current report
Jun 21, 2022 17:15 ET
Atea Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
May 10, 2022 16:09 ET
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
May 10, 2022 06:45 ET
Atea Pharmaceuticals | DEFA14A: Others
Apr 29, 2022 17:18 ET
Atea Pharmaceuticals | DEF 14A: Definitive proxy statements
Apr 29, 2022 17:16 ET
Atea Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Feb 28, 2022 18:23 ET
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Feb 28, 2022 16:11 ET
Atea Pharmaceuticals | 8-K: Current report
Jan 10, 2022 08:10 ET

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall